Repotrectinib increases KRAS-G12C inhibitor effectiveness via simultaneous inhibition of SRC, FAK, and JAK2

Murray, B; Deng, W; Zhai, D; Lee, NV; Rodon, L

EUROPEAN JOURNAL OF CANCER, 2020; 138 (): S39